Cleared Special

K261293 - EASYMAX Voice Blood Glucose Monitoring System

K261293 is an FDA 510(k) clearance for EASYMAX Voice Blood Glucose Monitoring ..., manufactured by Eps Bio Technology Corp.. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 186-day FDA review.

K261293 · Eps Bio Technology Corp. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2026
Decision
186d
Days
Class 2
Risk

K261293 is an FDA 510(k) clearance for the EASYMAX Voice Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Eps Bio Technology Corp. (Hsinchu, TW). The FDA issued a Cleared decision on October 23, 2026 after a review of 186 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K261293

510(k) Number K261293 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 2026
Decision Date October 23, 2026
Days to Decision 186 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d slower than avg
Panel avg: 89d · This submission: 186d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K261293.
Safe AQ Easy Blood Glucose Monitoring System
K260738 · Changsha Sinocare, Inc. · Oct 2026
VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System
K260687 · Vivachek Biotech (Hangzhou) Co., Ltd. · Oct 2026
CVS Advanced PLUS Blood Glucose Monitoring System
K260689 · I-Sens, Inc. · Oct 2026
CONTOUR® PLUS BLUE Blood Glucose Monitoring System
K260545 · Ascensia Diabetes Care · Aug 2026
TRUE METRIX Self Monitoring Blood Glucose System
K262116 · Trividia Health, Inc. · Jul 2026
On Call® Sure GK Blood Glucose & Ketone Monitoring System
K250085 · ACON Laboratories, Inc. · Oct 2025
K261293 · EASYMAX Voice Blood Glucose Monitoring System
Download PDF FDA Summary Eps Bio Technology Co…